Synonyms: Hengqu® | SHR-8735
hetrombopag is an approved drug (China (2021))
Compound class:
Synthetic organic
Comment: Hetrombopag is an orally bioavailable, non-peptide small‐molecule thrombopoietin receptor (TPOR/MPL) agonist, that was developed as a treatment for thrombocytopenia [1]. The parent compound is shown here. It is administered as the ethanolamine/olamine.
|
|
Classification | |
Compound class | Synthetic organic |
Approved drug? | Yes (China (2021)) |
IUPAC Name |
5-[2-hydroxy-3-[[5-methyl-3-oxo-2-(5,6,7,8-tetrahydronaphthalen-2-yl)-1H-pyrazol-4-yl]diazenyl]phenyl]furan-2-carboxylic acid |
Synonyms |
Hengqu® | SHR-8735 |
Database Links | |
CAS Registry No. | 1257792-41-8 |
GtoPdb PubChem SID | 404859104 |
PubChem CID | 135565610 |
Search Google for chemical match using the InChIKey | YATJUTCKRWETAB-UHFFFAOYSA-N |
Search Google for chemicals with the same backbone | YATJUTCKRWETAB |
UniChem Compound Search for chemical match using the InChIKey | YATJUTCKRWETAB-UHFFFAOYSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | YATJUTCKRWETAB-UHFFFAOYSA-N |